When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says




The Serum Institute of India said, “Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials.”



Source link

Leave a Comment

Your email address will not be published.